Yunkang Group Limited (HKG:2325)
Hong Kong · Delayed Price · Currency is HKD 0.5650
-0.0200 (-3.42%)
Oct 22, 2026, 2:36 PM HKT
Yunkang Group Market Cap
Yunkang Group has a market cap or net worth of 330.72 million as of October 21, 2026. It is the 31,132nd most valuable company in the world and the 1,602nd biggest in Hong Kong. Its market cap has decreased by 47.20% in one year.
Market Cap
330.72M
Enterprise Value
-759.31M
Revenue
624.49M
Global Rank
Country Rank
#1,602 Hong Kong
PE Ratio
4.72
ChartMarket Cap Chart
Since May 18, 2022, Yunkang Group's market cap has decreased from 5.21B to 330.72M, a decrease of -93.65%. That is a compound annual growth rate of -46.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 330.72M | -42.93% |
| Dec 31, 2025 | 579.49M | -89.52% |
| Dec 31, 2024 | 5.53B | -25.83% |
| Dec 29, 2023 | 7.46B | -25.55% |
| Dec 30, 2022 | 10.01B | 92.14% |
| May 18, 2022 | 5.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi XDC Cayman | 93.71B |
| Adicon Holdings | 3.22B |
| Mega Genomics | 1.60B |
| Kindstar Globalgene Technology | 900.42M |
| China Biotech Services Holdings | 497.62M |
| Biosino Bio-Technology and Science Incorporation | 448.59M |
| Zhong Ji Longevity Science Group | 315.14M |
| China NT Pharma Group Company | 298.93M |